Accuray (ARAY)
(Delayed Data from NSDQ)
$1.81 USD
+0.07 (4.02%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $1.82 +0.01 (0.55%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ARAY 1.81 +0.07(4.02%)
Will ARAY be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for ARAY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ARAY
Inogen (INGN) Down 0.1% Since Last Earnings Report: Can It Rebound?
Accuray (ARAY) Up 2% Since Last Earnings Report: Can It Continue?
ARAY: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for May 31st
New Strong Sell Stocks for May 24th
Accuray (ARAY) Q3 Earnings Lag Estimates, Gross Margin Contracts
Other News for ARAY
Director Joseph Whitters Acquires 100,000 Shares of Accuray Inc (ARAY)
12 Health Care Stocks Moving In Thursday's After-Market Session
Accuray to Participate in the Jefferies Global Healthcare Conference 2024
Accuray CFO Ali Pervaiz Steps in as Interim Accounting Officer
12 Health Care Stocks Moving In Thursday's Intraday Session